The role of nanotechnology in control of human diseases: perspectives in ocular surface diseases

Crit Rev Biotechnol. 2016 Oct;36(5):777-87. doi: 10.3109/07388551.2015.1036002. Epub 2015 Jul 20.

Abstract

Nanotechnology is the creation and use of materials and devices on the same scale as molecules and intracellular structures, typically less than 100 nm in size. It is an emerging science and has made its way into pharmaceuticals to significantly improve the delivery and efficacy of drugs in a number of therapeutic areas, due to development of various nanoparticle-based products. In recent years, there has been increasing evidence that nanotechnology can help to overcome many of the ocular diseases and hence researchers are keenly interested in this science. Nanomedicines offer promise as viable alternatives to conventional drops, gels or ointments to improve drug delivery to the eye. Because of their small size, they are well tolerated, thus preventing washout, increase bioavailability and also help in specific drug delivery. This review describes the application of nanotechnology in the control of human diseases with special emphasis on various eye and ocular surfaces diseases.

Keywords: Conjunctiva; drug delivery; nanomedicine; ocular diseases; ophthalmology; pterygium.

Publication types

  • Review

MeSH terms

  • Animals
  • Eye Diseases / drug therapy*
  • Humans
  • Nanoparticles / therapeutic use*
  • Nanotechnology